Good post Axelrod.
I think your scenarios 1 and 2 will be the most likely. I'm sure they will want the best reply possible to the FDA; and if that requires more time then so be it. Whether it is the response to the FDA by June 30, or a market update regarding needing more time, my thoughts are a 50/50 likelyhood either way.
Ann: IND QUESTIONS RECEIVED FROM US FDA, page-244
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |